Assay Detail
Functional
CHEMBL5043604
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antiviral activity against Influenza A virus A/Aichi/8/68(H3N2) strain infected in MDCK cells assessed as reduction in viral infection incubated for 48 hrs by crystal violet staining based assay
5
Total Activities
5
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Influenza A virus |
| Cell Type | MDCK |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| EC50 | 5 | 7.07 | 8.40 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL4297215 | BALOXAVIR | 2.0 | 1 | 8.40 |
| CHEMBL5088181 | — | — | 1 | 7.14 |
| CHEMBL5072629 | — | — | 1 | 7.07 |
| CHEMBL1200340 | OSELTAMIVIR PHOSPHATE | 4.0 | 1 | 5.65 |
| CHEMBL221722 | FAVIPIRAVIR | 4.0 | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL4297215 | BALOXAVIR | EC50 | = | 4.0 | nM | 8.40 |
| CHEMBL5088181 | — | EC50 | = | 72.0 | nM | 7.14 |
| CHEMBL5072629 | — | EC50 | = | 85.0 | nM | 7.07 |
| CHEMBL1200340 | OSELTAMIVIR PHOSPHATE | EC50 | = | 2250.0 | nM | 5.65 |
| CHEMBL221722 | FAVIPIRAVIR | EC50 | - | — | - |